Myristoylated alanine-rich C-kinase substrate as a prognostic biomarker in human primary lung squamous cell carcinoma

Cancer Biomarkers

Volumn 13, Issue 4, 2013, Pages 289-298

  Hanada, Shoji ^a   Kakehashi, Anna ^a   Nishiyama, Noritoshi ^a   Wei, Min ^a   Yamano, Shotaro ^a   Chung, Kyukwang ^a   Komatsu, Hiroaki ^a   Inoue, Hidetoshi ^a   Suehiro, Shigefumi ^a   Wanibuchi, Hideki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Lung cancer; proteomics; squamous cell carcinoma

Indexed keywords

ACTIN BINDING PROTEIN; ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; ALPHA ENOLASE; CALGRANULIN A; CALGRANULIN B; CALRETICULIN; CHAPERONIN 60; CHAPERONIN CONTAINING TCP1; CYTOKERATIN 15; CYTOKERATIN 17; CYTOKERATIN 19; CYTOKERATIN 5; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEPATOMA DERIVED GROWTH FACTOR; KARYOPHERIN; KERATIN 6A; KHELLIN; LECTIN; MARCKS PROTEIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN DISULFIDE ISOMERASE; PROTEIN KINASE C; PROTHYMOSIN ALPHA; TENASCIN; THIOREDOXIN; TRANSCRIPTION FACTOR RUNX2; TUMOR MARKER; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

LUNG CANCER; PROTEOMICS; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MASS SPECTROMETRY; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84888594904     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130354     Document Type: Article

References (36)

1. Li C, Xiao Z, Chen Z, Zhang X, Li J,Wu X, Li X, Yi H, Li M, Zhu G, Liang S, Proteome analysis of human lung squamous carcinoma. Proteomics 6 (2006) 547-58.
2. Shirakusa TKK, Lung cancer in Japan. Analysis of lung cancer registry for resected cases in 1994. Japanese Journal of Lung Cancer 42 (2002) 555-66.
3. Granville CA, Dennis PA, An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol 32 (2005) 169-76.
4. Sung HJ, Cho JY, Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep 41 (2008) 615-25.
5. Daigo Y, Nakamura Y, From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma. Gen Thorac Cardiovasc Surg 56 (2008) 43-53.
6. DeSouza LV, Grigull J, Ghanny S, Dube V, Romaschin AD, Colgan TJ, Siu KW, Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 6 (2007) 1170-82.
7. Dube V, Grigull J, DeSouza LV, Ghanny S, Colgan TJ, Romaschin AD, Siu KW, Verification of endometrial tissue biomarkers previously discovered using mass spectrometrybased proteomics by means of immunohistochemistry in a tissue microarray format. J Proteome Res 6 (2007) 2648-55.
8. Ocak S, Chaurand P, Massion PP, Mass spectrometry-based proteomic profiling of lung cancer. Proc Am Thorac Soc 6 (2009) 159-70.
9. Zieske LR, A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 57 (2006) 1501-8.
10. Picotti P, Bodenmiller B, Mueller LN, Domon B, Aebersold R, Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138 (2009) 795-806.
11. Chung K, Nishiyama N, Yamano S, Komatsu H, Hanada S, Wei M, Wanibuchi H, Suehiro S, Kakehashi A, Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma. Cancer Biomarkers 10 (2011) 101-7.
12. Kakehashi A, Ishii N, Shibata T, Wei M, Okazaki E, Tachibana T, Fukushima S, Wanibuchi H, Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis. Toxicol Sci 119 (2011) 61-72.
13. Gluckmann M, Fella K, Waidelich D, Merkel D, Kruft V, Kramer PJ,Walter Y, Hellmann J, KarasM, KrogerM, Preval idation of potential protein biomarkers in toxicology using iTRAQ reagent technology. Proteomics 7 (2007) 1564-74.
14. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, Histological of lung and pleural tumors: World Health Organization international histological classification of tumors. 3rd ed. Berlin: Springer, 1999.
15. Rami-Porta R, Crowley JJ, Goldstraw P, The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 15 (2009) 4-9.
16. Song X, Bandow J, Sherman J, Baker JD, Brown PW, Mc-Dowell MT, Molloy MP, iTRAQ experimental design for plasma biomarker discovery. J Proteome Res 7 (2008) 2952-8.
17. Ralhan R, Desouza LV, Matta A, Tripathi SC, Ghanny S, Dattagupta S, Thakar A, Chauhan SS, Siu KW, iTRAQmultidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J Proteome Res 8 (2009) 300-9.
18. Hsu SM, Raine L, Fanger H, Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29 (1981) 577-80.
19. Matta A, DeSouza LV, Shukla NK, Gupta SD, Ralhan R, Siu KW, Prognostic significance of head-andneck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography- tandem mass spectrometry. J Proteome Res 7 (2008) 2078-87.
20. Blackshear PJ, The MARCKS family of cellular protein kinase C substrates. J Biol Chem 269 (1993) 1501-4.
21. Hartwig JH, Thelen M, Rosen A, Janmey PA, Nairn AC, Aderem A, MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 356 (1992) 618-22.
22. Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S, Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. Int J Oncol 26 (2005) 661-71.
23. Li T, Li D, Sha J, Sun P, Huang Y, MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 383 (2009) 280-5.
24. Graff JM, Young TN, Johnson JD, Blackshear PJ, Phosphorylation-regulated calmodulin binding to a prominent cellular substrate for protein kinase C. J Biol Chem 264 (1989) 21818-23.
25. McIlroy BK, Walters JD, Blackshear PJ, Johnson JD, Phosphorylation- dependent binding of a synthetic MARCKS peptide to calmodulin. J Biol Chem 266 (1991) 4959-64.
26. Manenti S, Malecaze F, Darbon JM, The major myristoylated PKC substrate (MARCKS) is involved in cell spreading, tyrosine phosphorylation of paxillin, and focal contact formation. FEBS Lett 419 (1997) 95-8.
27. Micallef J, Taccone M, Mukherjee J, Croul S, Busby J,Moran MF, Guha A, Epidermal growth factor receptor variant IIIinduced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Cancer Res 69 (2009) 7548-56.
28. Wei Y, Tong J, Taylor P, Strumpf D, Ignatchenko V, Pham NA, Yanagawa N, Liu G, Jurisica I, Shepherd FA, Tsao MS, Kislinger T, Moran MF, Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. J Proteome Res 10 (2011) 161-74.
29. LiA,Yan WS, Liang QW, Liu JH,Wang JX, Zhao S, Fang Y, Identification of stage Ib specific related genes in lung squamous cell cancer by oligonucleotide array. Zhonghua Yi Xue Za Zhi 85 (2005) 2623-8.
30. Buhrens RI, Amelung JT, Reymond MA, Beshay M, Protein expression in human non-small cell lung cancer: a systematic database. Pathobiology 76 (2009) 277-85.
31. Katsantonis J, Tosca A, Koukouritaki SB, Theodoropoulos PA, Gravanis A, Stournaras C, Differences in the G/total actin ratio and microfilament stability between normal and malignant human keratinocytes. Cell Biochem Funct 12 (1994) 267-74.
32. Malliri A, Symons M, Hennigan RF, Hurlstone AFL, Lamb RF, Wheeler T, Ozanne BW, The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J Cell Biol 143 (1998) 1087-99.
33. Hussenet T, du Manoir S, SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis. Cell Cycle 9 (2011) 1480-6.
34. Jiang R, Jin Z, Liu Z, Sun L, Wang L, Li K, Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma. Mol Diagn Ther 15 (2011) 347-52.
35. Garte SJ, The c-myc oncogene in tumor progression. Crit Rev Oncog 4 (1993) 435-49.
36. Lee JH, Lee DH, Park SS, Seok SE, Lee JD, Oncogene expression detected by in situ hybridization in human primary lung cancer. Chest 94 (1988) 1046-9.